San Francisco, April 04, 2016 -- Global autoimmune disease diagnostics market is expected to reach USD 14.17 billion by 2020. Growing prevalence of autoimmune diseases coupled with the presence of favorable government initiatives such as the Affordable Care Act is expected to positively reinforce the autoimmune disease diagnostics market. Slow turnaround duration and presence of fewer diagnostic tests catering to nearly 80 disease types and the consequent rise in lab automation rates are expected to drive market growth during the forecast period. Automation of laboratories is expected enable clinicians with the ability to conduct several diagnostic tests simultaneously and generate accurate and rapid results. Technological advances such as the development of novel biomarkers and portable diagnostic point of care equipment are further expected to boost procedure volumes.
Browse Full Research Report With TOC On "Autoimmune Disease Diagnostics Market Shares, Strategies, and Forecasts, Worldwide, 202o" at: www.radiantinsights.com/research/autoimmune-disease-diagnostics-market-analysis-by-product-systemic-localized-rheumatoid-arthritis-systemic-lupus-erythematosus-ankylosing-spondylitis-and-segment-forecasts-to-2020
Systemic autoimmune disease diagnostics is the most lucrative segment of this market. Presence of high unmet patient needs in disease segments such as rheumatoid arthritis and systemic lupus E. coupled with the introduction of new products for example Avise SLE marker for lupus diagnosis are some factors expected to drive segment growth over the next six years. In addition, implementation of initiatives aimed at developing effective diagnostic and therapeutic solutions for systemic diseases with high prevalence for instance rheumatoid arthritis is further expected to drive segment growth.
Further key findings from the study suggest:
- Rheumatoid arthritis emerged as the fastest growing product segment. Its market is expected to grow at a CAGR of over 4.0% from 2014 to 2020. High prevalence of rheumatoid arthritis and the involvement of expensive assessment tests are few factors attributing to its rapid growth.
- Localized autoimmune disease diagnostics was the leading product segment of this market in 2013. Extensive presence of commercialized diagnostic products and growing prevalence of gastrointestinal autoimmune disorders are some factors accounting for its large share.
- North America was the largest regional market in 2013, accounting for a share of over 40.0%. Its large share is attributed by the introduction of the Affordable Care Act, presence of favorable initiatives undertaken by the AARDA and high disease prevalence levels in the region.
- Asia Pacific is expected to witness promising growth over the next six years. Constantly improving healthcare infrastructure and patient awareness levels in the emerging markets of India and China have now opened up new avenues for the manufacturers to capitalize on.
- Some key players of the autoimmune disease diagnostics market include Abbott Laboratories, Quest Diagnostics, Siemens Healthcare, Beckman Coulter Inc. and SQI Diagnostics.
- Introduction of technologically innovative products such as Celiac panel tests enabling faster IgG & IgA antibodies detection is one of the major sustainability strategies adopted by the market players
See More Reports of This Category by Radiant Insights: www.radiantinsights.com/catalog/healthcare
Global Autoimmune Disease Diagnostics Product Outlook (Revenue, USD Billion, 2012 - 2020)
- Systemic Autoimmune Disease Diagnostics
- Rheumatoid Arthritis Diagnostics
- Ankylosing Spondylitis Diagnostics
- Systemic Lupus Erythematosus (SLE)
- Localized Autoimmune Disease Diagnostics
Autoimmune Disease Diagnostics Regional Outlook (Revenue, USD Billion, 2012 - 2020)
- North America
- S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- China
- Japan
- RoW
- Brazil
Explore Other Reports By Radiant Insights,Inc at
- Paint Industry –
http://www.radiantinsights.com/research/paint-industry-forecasts-china-focus
- Polybutadiene Rubber Industry –
http://www.radiantinsights.com/research/polybutadiene-rubber-industry-forecasts-china-focus
- Rubber Smoked Sheet Industry –
http://www.radiantinsights.com/research/rubber-smoked-sheet-industry-forecasts-china-focus
About Radiant Insights
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy.Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: [email protected]
Web: http://www.radiantinsights.com/


Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle
CATL Stock Hits Record High After Q1 2025 Earnings Surge
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 



